FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:2378-2387 May 29, 2008 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Video Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The hepatopulmonary syndrome is characterized by a defect in arterial oxygenation induced by pulmonary vascular dilatation in the setting of liver disease¹; patients of all ages can be affected. This clinical syndrome has three components: liver disease, pulmonary vascular dilatation, and a defect in oxygenation. A classification of the severity of the hepatopulmonary syndrome based on abnormalities in oxygenation is vital because severity influences survival and is useful in determining the timing and risks of liver transplantation (Table 1). The vascular component includes diffuse or localized dilated pulmonary capillaries and, less commonly, pleural and pulmonary arteriovenous communications. . . . [Full Text of this Article]

Clinical Manifestations

Prevalence and Natural History

Pathobiology

Treatment

Source Information

From Servei de Pneumologia (Institut del Tòrax), Hospital Clínic, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Ciber Enfermedades Respiratorias, and the University of Barcelona — all in Barcelona; and the Pulmonary and Critical Care Division, Mayo Clinic, Rochester, MN.

Address reprint requests to Dr. Rodríguez-Roisin at Servei de Pneumologia, Hospital Clínic, Villarroel, 170, E-08036 Barcelona, Spain, or at rororo@clinic.ub.es.

Related Letters:

The Hepatopulmonary Syndrome
Ghent C. N., Levstik M. A., Marotta P. J., Szmigielski C., Krenke R., Styczynski G., Viles-Gonzalez J. F., Rodríguez-Roisin R., Krowka M. J.
Extract | Full Text | PDF  
N Engl J Med 2008; 359:866-867, Aug 21, 2008. Correspondence

This article has been cited by other articles:

• Jones, R. L., Sheel, A. W., Naeije, R., Hughes, J. M. B., Bates, M. L. (2009). Pathophysiological insight into shunted bubbles.. J. Appl. Physiol. 107: 999-1000 [Full Text]  
• Degano, B., Mittaine, M., Herve, P., Rami, J., Kamar, N., Suc, B., Riviere, D., Rostaing, L. (2009). Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. Eur Respir J 34: 138-144 [Abstract] [Full Text]  
• Degano, B., Mittaine, M., Guenard, H., Rami, J., Garcia, G., Kamar, N., Bureau, C., Peron, J.-M., Rostaing, L., Riviere, D. (2009). Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J. Appl. Physiol. 107: 139-143 [Abstract] [Full Text]  
• Tieppo, J., Cuevas, M. J., Vercelino, R., Tunon, M. J., Marroni, N. P., Gonzalez-Gallego, J. (2009). Quercetin Administration Ameliorates Pulmonary Complications of Cirrhosis in Rats. J. Nutr. 139: 1339-1346 [Abstract] [Full Text]  
• MacLaren, R. (2009). Management of Cirrhosis and Associated Complications. Journal of Pharmacy Practice 22: 290-309 [Abstract]  
• Yeshua, H., Blendis, L. M., Oren, R. (2009). Pulmonary Manifestations of Liver Diseases. SEMIN CARDIOTHORAC VASC ANESTH 13: 60-69 [Abstract]  
• Su, T.-H., Liu, W.-L., Yu, C.-J., Huang, G.-T. (2009). Unusual dyspnoea in a patient with liver cirrhosis. BMJ Case Reports 2009: bcr0620080250-bcr0620080250 [Abstract] [Full Text]  
• Rosen, M. J. (2009). Other Pulmonary Disorders. ACCP Pulmonary Med Brd Rev 25: 285-294 [Full Text]  
• Ghent, C. N., Levstik, M. A., Marotta, P. J., Szmigielski, C., Krenke, R., Styczynski, G., Viles-Gonzalez, J. F., Rodriguez-Roisin, R., Krowka, M. J. (2008). The Hepatopulmonary Syndrome. NEJM 359: 866-867 [Full Text]